Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000599308 | SCV000710501 | likely pathogenic | not provided | 2019-06-13 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016) |
Labcorp Genetics |
RCV000984320 | SCV001586998 | pathogenic | Cohen syndrome | 2023-11-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln2375*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant is present in population databases (rs767858119, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 504191). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000984320 | SCV001132505 | likely pathogenic | Cohen syndrome | 2014-04-20 | no assertion criteria provided | clinical testing |